Evidence map›Paper›PMID 32548968›Full record

ArticleESC heart failure2020

Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics.

Abdulla Ahmed, Salaheldin Ahmed, Mattias Arvidsson, Habib Bouzina, Jakob Lundgren, Göran Rådegran

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Abdulla AhmedDepartment of Clinical Sciences, Lund, The Section for Cardiology, Lund University, Lund, Sweden.ORCID 0000-0001-6005-5300
Salaheldin AhmedDepartment of Clinical Sciences, Lund, The Section for Cardiology, Lund University, Lund, Sweden.ORCID 0000-0001-7086-6262
Mattias ArvidssonDepartment of Clinical Sciences, Lund, The Section for Cardiology, Lund University, Lund, Sweden.ORCID 0000-0001-5315-7819
Habib BouzinaDepartment of Clinical Sciences, Lund, The Section for Cardiology, Lund University, Lund, Sweden.ORCID 0000-0002-9956-7060
Jakob LundgrenDepartment of Clinical Sciences, Lund, The Section for Cardiology, Lund University, Lund, Sweden.ORCID 0000-0001-9338-2906
Göran RådegranDepartment of Clinical Sciences, Lund, The Section for Cardiology, Lund University, Lund, Sweden.ORCID 0000-0003-4919-2771
Valve (United States) · US

Funding

Actelion Pharmaceuticals Sweden ABAvtal om läkarutbildning och forskning
6 · The paper itself

Abstract

aimsMetabolic derangement is implicated in the pathophysiology of heart failure (HF) and pulmonary hypertension (PH). We aimed to identify the dynamics of metabolic plasma proteins linked to end-stage HF and associated PH in relation to haemodynamics, before and after heart transplantation (HT). METHODS AND

resultsTwenty-one metabolic plasma proteins were analysed with proximity extension assay in 20 controls and 26 patients before and 1 year after HT. Right heart catheterizations were performed in the HF patients pre-operatively and 1 year after HT. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and insulin-like growth factor-binding protein 7 (IGFBP7) were higher in HF patients compared with controls (P < 0.0001) and decreased after HT (P < 0.0001), matching controls' levels. The decrease in sRAGE after HT correlated with improved mean pulmonary arterial pressure (r

conclusionsOur results indicate that plasma sRAGE may reflect passive pulmonary vascular congestion and the 'mechanical' state of the pulmonary vasculature in HF patients with or without related PH. Furthermore, sRAGE and IGFBP7 may provide additional insight into the pathophysiological mechanisms in HF and associated PH. Their potential clinical and therapeutic relevance in HF and associated PH need further investigation.

Indexed as

Heart FailureHeart TransplantationBiomarkersCase-Control StudiesHemodynamicsHumansInsulin-Like Growth Factor Binding ProteinsReceptor for Advanced Glycation End ProductsBiomarkersinsulin-like growth factor binding protein-related protein 1Insulin-Like Growth Factor Binding ProteinsReceptor for Advanced Glycation End ProductsBiomarkersHaemodynamicsHeart failureHeart transplantationMetabolismPulmonary hypertension

Identifiers

PMID32548968
PMCPMC7524060
OpenAlexW3035022847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.